These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34482194)

  • 1. Dopaminergic and serotonergic alterations in plasma in three groups of dystonia patients.
    Timmers ER; van Faassen M; Smit M; Kuiper A; Hof IH; Kema IP; Tijssen MAJ; Niezen-Koning KE; de Koning TJ
    Parkinsonism Relat Disord; 2021 Oct; 91():48-54. PubMed ID: 34482194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic system in vivo with [
    Timmers ER; Peretti DE; Smit M; de Jong BM; Dierckx RAJO; Kuiper A; de Koning TJ; Vállez García D; Tijssen MAJ
    Sci Rep; 2022 Apr; 12(1):6292. PubMed ID: 35428769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to levodopa treatment in dopa-responsive dystonia.
    Nutt JG; Nygaard TG
    Arch Neurol; 2001 Jun; 58(6):905-10. PubMed ID: 11405805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopa-responsive dystonia, DRD-plus and DRD look-alike: a pragmatic review.
    Cherian A; Paramasivan NK; Divya KP
    Acta Neurol Belg; 2021 Jun; 121(3):613-623. PubMed ID: 33453040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myoclonus-dystonia: Distinctive motor and non-motor phenotype from other dystonia syndromes.
    Timmers ER; Smit M; Kuiper A; Bartels AL; van der Veen S; van der Stouwe AMM; Santens P; Bergmans B; Tijssen MAJ
    Parkinsonism Relat Disord; 2019 Dec; 69():85-90. PubMed ID: 31706131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new knock-in mouse model of l-DOPA-responsive dystonia.
    Rose SJ; Yu XY; Heinzer AK; Harrast P; Fan X; Raike RS; Thompson VB; Pare JF; Weinshenker D; Smith Y; Jinnah HA; Hess EJ
    Brain; 2015 Oct; 138(Pt 10):2987-3002. PubMed ID: 26220941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of the serotonin reuptake transporter gene and non-motor symptoms in dystonia patients.
    Timmers ER; Plösch T; Smit M; Hof IH; Verkaik-Schakel RN; Tijssen MAJ; de Koning TJ; Niezen-Koning KE
    Clin Epigenetics; 2022 Dec; 14(1):170. PubMed ID: 36503539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.
    Cheshire P; Ayton S; Bertram KL; Ling H; Li A; McLean C; Halliday GM; O'Sullivan SS; Revesz T; Finkelstein DI; Storey E; Williams DR
    Mov Disord; 2015 May; 30(6):796-804. PubMed ID: 25649148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-motor symptoms and quality of life in dopa-responsive dystonia patients.
    Timmers ER; Kuiper A; Smit M; Bartels AL; Kamphuis DJ; Wolf NI; Poll-The BT; Wassenberg T; Peeters EAJ; de Koning TJ; Tijssen MAJ
    Parkinsonism Relat Disord; 2017 Dec; 45():57-62. PubMed ID: 29066160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopa-Responsive Dystonia and gait analysis: A case study of levodopa therapeutic effects.
    Rebour R; Delporte L; Revol P; Arsenault L; Mizuno K; Broussolle E; Luauté J; Rossetti Y
    Brain Dev; 2015 Jun; 37(6):643-50. PubMed ID: 25282485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia.
    Clot F; Grabli D; Cazeneuve C; Roze E; Castelnau P; Chabrol B; Landrieu P; Nguyen K; Ponsot G; Abada M; Doummar D; Damier P; Gil R; Thobois S; Ward AJ; Hutchinson M; Toutain A; Picard F; Camuzat A; Fedirko E; Sân C; Bouteiller D; LeGuern E; Durr A; Vidailhet M; Brice A;
    Brain; 2009 Jul; 132(Pt 7):1753-63. PubMed ID: 19491146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual signs of dopa-responsive dystonia with GCH1 mutation following levodopa treatment are uncommon in Korean patients.
    Ahn TB; Chung SJ; Koh SB; Park HY; Cho JW; Lee JH; Hong JY; Kwon DY; Shin C; Lee JY; Lee WW; Jeon B
    Parkinsonism Relat Disord; 2019 Aug; 65():248-251. PubMed ID: 31213404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor fluctuations and levodopa-induced dyskinesias in dopa-responsive dystonia.
    Bendi VS; Shou J; Joy S; Torres-Russotto D
    Parkinsonism Relat Disord; 2018 May; 50():126-127. PubMed ID: 29467094
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dopa-responsive dystonia: clinical, genetic, and biochemical studies].
    Furukawa Y
    Rinsho Shinkeigaku; 2006 Jan; 46(1):19-34. PubMed ID: 16541791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice.
    Yokoi F; Dang MT; Li J; Li Y
    J Biochem; 2006 Jul; 140(1):141-6. PubMed ID: 16815860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the Spectrum of Dopa-Responsive Dystonia (DRD) and Proposal for New Definition: DRD, DRD-plus, and DRD Look-alike.
    Lee WW; Jeon B; Kim R
    J Korean Med Sci; 2018 Jul; 33(28):e184. PubMed ID: 29983692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcranial sonography in dopa-responsive dystonia.
    Svetel M; Tomić A; Mijajlović M; Dobričić V; Novaković I; Pekmezović T; Brajković L; Kostić VS
    Eur J Neurol; 2017 Jan; 24(1):161-166. PubMed ID: 27731537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-motor phenotype of dopa-responsive dystonia and quality of life assessment.
    Brüggemann N; Stiller S; Tadic V; Kasten M; Münchau A; Graf J; Klein C; Hagenah J
    Parkinsonism Relat Disord; 2014 Apr; 20(4):428-31. PubMed ID: 24444533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of 15 cases of Dopa-responsive dystonia].
    Yang J; Yuan XQ; Xiao L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):725-6. PubMed ID: 16114571
    [No Abstract]   [Full Text] [Related]  

  • 20. Hereditary progressive dystonia with marked diurnal fluctuation.
    Segawa M
    Brain Dev; 2000 Sep; 22 Suppl 1():S65-80. PubMed ID: 10984664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.